BodySculpt(TM) Leads FDA Approval of BodyTite(TM) with Largest Number of Documented Study Cases

The plastic surgeons at BodySculpt(TM) are revolutionizing the latest techniques in liposuction -- one radio-frequency wave at a time. Since being selected by Invasix to head the FDA approval studies of BodyTite(TM), BodySculpt(TM) has lead the industry in its number of case studies and field research. The latest device in body-contouring procedures, BodyTite(TM) utilizes radio-frequency assisted liposuction (RFAL) technology. With the direction of board certified BodySculpt(TM) Surgical Director Dr. Christopher Chia BodySculpt(TM) is the first team of surgeons in the New York area to use BodyTite(TM) and is the leading authority in RFAL and its introduction to the world of plastic surgery.

BodyTite(TM) is the most compact and ergonomic, energy-assisted liposuction device in the world, in addition to being powerful, minimally invasive and safe. BodyTite(TM) liposuction procedures not only produce successful fat removal with less downtime, but also improve patient safety and comfort.

After conducting several case studies on women with postpartum body insecurities, the plastic surgeons at BodySculpt(TM) have even deemed it as the "virtual no scar tummy-tuck". The RFAL technology induces simultaneous tissue liquefaction, blood vessel coagulation, and heating of the skin, which results in optimal soft tissue contraction and skin tightening. This makes the procedure ideal for postpartum patients or others with compromised skin laxity, such as those who have just experienced extreme weight loss.

Having conducted the largest number of study cases of the procedure in the US, the impressive findings of the doctors at BodySculpt(TM) will aide in determining industry-wide effectiveness and safety standards of BodyTite(TM) once approved by the FDA. Results, reactions, and conclusions thus far have been extremely positive and successful- great news for the FDA approval process, potential patients and surgeons alike.